IRIS
DE LUCA, GIACOMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 833
NA - Nord America 634
AS - Asia 306
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 1.780
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 631
SE - Svezia 447
IT - Italia 149
CN - Cina 127
SG - Singapore 123
RU - Federazione Russa 112
FI - Finlandia 42
DE - Germania 25
PH - Filippine 18
IN - India 10
NL - Olanda 10
IE - Irlanda 9
FR - Francia 8
KR - Corea 8
UA - Ucraina 7
GB - Regno Unito 6
NO - Norvegia 6
TR - Turchia 6
IR - Iran 5
MK - Macedonia 4
PT - Portogallo 3
CA - Canada 2
EU - Europa 2
HK - Hong Kong 2
HU - Ungheria 2
JP - Giappone 2
MY - Malesia 2
PE - Perù 2
TN - Tunisia 2
AL - Albania 1
DZ - Algeria 1
GR - Grecia 1
ID - Indonesia 1
IL - Israele 1
MX - Messico 1
SI - Slovenia 1
UZ - Uzbekistan 1
Totale 1.780
Salva come PNG Salva come JPEG
Città #
Shanghai 103
Lawrence 99
Princeton 99
New York 74
Singapore 67
Moscow 64
Ashburn 59
Boardman 52
Helsinki 41
Milan 34
Rome 14
Los Angeles 10
Dublin 9
Makati City 9
Seattle 8
Seongnam-si 8
Oslo 6
Pune 6
Howell 5
Verona 5
Ancona 4
Dronten 4
Florence 4
Istanbul 4
Mestrino 4
Quezon City 4
Vaprio d'Adda 4
Amadora 3
Angera 3
Cabanatuan City 3
Gallarate 3
Osimo 3
Skopje 3
Springfield 3
Vittoria 3
Angers 2
Ankara 2
Arezzo 2
Arnsberg 2
Castel Mella 2
Catania 2
Dalmine 2
Enschede 2
Foshan 2
Honcho 2
Hyde Park 2
Lima 2
Marana 2
Mykolayiv 2
New Delhi 2
Orani 2
Padova 2
Paris 2
Petaling Jaya 2
Pécs 2
San Mateo 2
Segrate 2
St Petersburg 2
Torre Del Greco 2
Vignola 2
Washington 2
West Jordan 2
York 2
Aci Catena 1
Amsterdam 1
Athens 1
Balasore 1
Borås 1
Capaccio 1
Certaldo 1
Dallas 1
Falkenstein 1
Fiumefreddo Di Sicilia 1
Forest City 1
Frankfurt am Main 1
Galliate 1
Gatchina 1
Giv‘atayim 1
Hanover 1
Issogne 1
Jakarta 1
Kish 1
Lainate 1
Lappeenranta 1
Laurel 1
Ljubljana 1
London 1
Maidenhead 1
Monterrey 1
Mountain View 1
Naaldwijk 1
Nuremberg 1
Pacific Palisades 1
Paliano 1
Perm 1
Pisa 1
Quanzhou 1
Redwood City 1
Sacramento 1
San Giovanni In Persiceto 1
Totale 917
Salva come PNG Salva come JPEG
Nome #
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 45
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 44
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series 36
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 33
Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli 32
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 27
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 27
Cardiac magnetic resonance in systemic sclerosis myocarditis: the value of T2 mapping to detect myocardial inflammation 27
Arrhythmias in Myocarditis: State of the Art 25
Adult leukoencephalopathies with prominent infratentorial involvement can be caused by Erdheim-Chester disease 24
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 24
DRUG RETENTION RATES OF BIOLOGICAL AGENTS IN ADULT ONSET STILL'S DISEASE IN THE PRE-CANAKINUMAB ERA 24
The spectrum of covid-19-associated myocarditis: A patient-tailored multidisciplinary approach 24
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study 23
Does the impact of COVID-19 on patients with systemic sclerosis change over time? 22
Exercise Stress Test Late after Arrhythmic versus Nonarrhythmic Presentation of Myocarditis 22
Assessing the role of pentraxin-3 in Takayasu's arteritis. Comment on: Plasma pentraxin-3 levels in patients with Takayasu's arteritis during routine follow-up. Alibaz-Oner F. et al 22
The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis 22
Cardiac magnetic resonance findings in acute and post-acute COVID-19 patients with suspected myocarditis 21
C3-glomerulopathy and MGUS: The skin beyond the kidney 21
Anti-PD1 therapy-associated cutaneous leucocytoclastic vasculitis: A case series 21
A Novel Histiocytosis With Synovial and Skin Involvement 21
Canakinumab injection for the treatment of active Still’s disease, including adult-onset Still’s disease 21
Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases 21
Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease 20
Therapeutic strategies for virus-negative myocarditis: a comprehensive review 20
B cells in systemic sclerosis: A possible target for therapy 20
Drug retention rates of biological agents in adult onset Still's disease 20
Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. 20
Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities 19
Advances in potential targeted therapies for Erdheim-Chester disease 19
Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience 19
Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis 19
Immunosuppressive Therapy and Risk Stratification of Patients With Myocarditis Presenting With Ventricular Arrhythmias 19
Heart Involvement in Systemic Sclerosis: the Role of Magnetic Resonance Imaging 19
Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis 18
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study 18
Anti-Ku syndrome with elevated CK: Association with myocardial involvement in systemic sclerosis 18
Cardiac immune-related adverse events: an immune-cardio-oncology puzzle 18
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 18
Pruritus characteristics in a large Italian cohort of psoriatic patients 17
Cardiac magnetic resonance in systemic sclerosis patients with cardiac symptoms: do we really need it? 17
Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: The Role of Endomyocardial Biopsy 17
Tocilizumab for the Treatment of Myocardial Inflammation Shown by Cardiac Magnetic Resonance: Report of Two Cases and Rationale for Its Therapeutic Use 17
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study 17
Inflammation as a Predictor of Recurrent Ventricular Tachycardia After Ablation in Patients With Myocarditis 17
Efficacy and safety of mycophenolate mofetil in patients with virus-negative lymphocytic myocarditis: A prospective cohort study 17
Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease 17
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 17
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 16
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production 16
Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group 16
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review 16
Hybrid FDG-PET/MR or FDG-PET/CT to Detect Disease Activity in Patients With Persisting Arrhythmias After Myocarditis 16
ASSOCIAZIONE TRA MALATTIA IGG4-CORRELATA E IMMUNOTERAPIA ALLERGENE-SPECIFICA. STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO. 16
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers 16
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 16
Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases 16
Primary heart involvement in systemic sclerosis, from conventional to innovative targeted therapeutic strategies 16
Generalized morphea after COVID-19 vaccines: a case series 15
QTc interval prolongation in Systemic Sclerosis: Correlations with clinical variables and arrhythmic risk 15
Efficacy and Safety of Methotrexate for the Treatment of Autoimmune Virus-Negative Myocarditis: A Case Series 15
Unexpected acute lymphocytic virus-negative myocarditis in a patient with limited cutaneous systemic sclerosis: a case report 15
Low prevalence of arrhythmias in clinically stable COVID-19 patients 15
Telemedicine in myocarditis: Evolution of a mutidisciplinary “disease unit” at the time of COVID-19 pandemic 15
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 15
Association of anti-RNA polymerase III antibody with silicone breast implants rupture in a multicentre series of Italian patients with systemic sclerosis 15
Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition 15
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience 15
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 15
Successful use of cyclosporin A and interleukin-1 blocker combination therapy in VEXAS syndrome: a single-center case series 14
Safety and efficacy of rituximab biosimilar (CT-P10) in systemic sclerosis: an Italian multicentre study 14
Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still's disease (Arthritis Research and Therapy (2019) 21 (54) DOI: 10.1186/s13075-019-1843-9) 14
Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study 14
Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburst 14
Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic 14
Severe acute respiratory syndrome coronavirus-2-induced flare of systemic sclerosis 14
Cardiac Safety of mRNA-based Vaccines in Patients with Systemic Lupus Erythematosus and Lupus-like Disorders with a History of Myocarditis 14
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 13
Serum organ-specific anti-heart and anti-intercalated disk autoantibodies as new autoimmune markers of cardiac involvement in systemic sclerosis: Frequency, clinical and prognostic correlates 13
Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis 13
The fibrogenic chemokine CCL18 is associated with disease severity in Erdheim-Chester disease 13
Treatment of Dilated Cardiomyopathy With Interleukin-1 Inhibition 13
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 13
MAVRILIMUMAB IMPROVES OUTCOMES IN SEVERE COVID-19 PNEUMONIA AND SYSTEMIC HYPERINFLAMMATION 13
Patient-reported outcome instruments in clinical trials of systemic sclerosis 13
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study 13
ENVIRONMENTAL POLLUTION AND SYSTEMIC SCLEROSIS: A PILOT STUDY ON BENZENE AND PARTICULATE EXPOSURE AS RISK FACTORS FOR THE SYSTEMIC MANIFESTATIONS 13
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression 13
Troponin in Stable Ischemic Heart Disease and Diabetes 13
Improvements of vascular outcomes in systemic sclerosis: halfway through, but still far to go 13
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors 12
Clinical profiling and outcomes of viral myocarditis manifesting with ventricular arrhythmias 12
Myocarditis as a manifestation of Erdheim–Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapy 12
Successful use of sirolimus in a patient with cardiac microangiopathy in primary antiphospholipid syndrome 12
Diagnostic approach and novel therapeutic option for cardiac inflammatory disorders. Comment on “Antisynthetase syndrome and cardiac involvement: a rare association” by Meudec et al. Joint Bone Spine 2018. doi: 10.1016/j.jbspin.2018.09.019 12
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 12
Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac Involvement 12
Immunometabolic activation of macrophages leads to cytokine production in the pathogenesis of KRAS-mutated histiocytosis 12
Myocarditis: An Interleukin-1-Mediated Disease? 11
Totale 1.799
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.741
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.741
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202020 3 0 0 0 0 0 0 0 1 0 15 1
2020/202148 3 0 5 10 0 12 8 3 1 0 4 2
2021/2022249 1 0 102 46 9 16 4 7 11 31 5 17
2022/2023784 250 176 55 4 16 97 40 72 35 11 15 13
2023/2024744 25 56 75 67 65 111 42 82 5 33 36 147
2024/2025202 202 0 0 0 0 0 0 0 0 0 0 0
Totale 2.066